An article on EU fisheries policy, published in the edition of August 30th, quoted from a report by Kevin Flannery of the Sea Fisheries Protection Authority (SFPA). Mr Flannery compiled the report while with the SFPA but has now retired. The error occurred in the editing process.
An article in the HEALTHplus supplement last Tuesday quoted a figure of € 30 million per year as the total cost for the provision of two new Hepatitis C products, Telaprevir and Boceprevir. The actual cost of provision of these drugs, as stated by the HSE, is €8-10 million for next year.